Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137


Knowledge of how the immune system recognizes and attempts to control cancer growth and development has improved dramatically. The advent of immunotherapies for cancer has resulted in robust clinical responses and confirmed that the immune system can significantly inhibit tumor progression. Until recently, metastatic melanoma was a disease with limited… (More)
DOI: 10.2147/CPAA.S46199


3 Figures and Tables

Slides referencing similar topics